Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes’ B and C colorectal carcinoma. A cost-effectiveness analysis

EuroQol - a new facility for the measurement of health-related quality of life

1990 • 14,363 citations

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

1990 • 2,226 citations

Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma

1991 • 1,888 citations

Harrison's Principles of Internal Medicine.

1991 • 1,573 citations

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer

1995 • 1,043 citations

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

1989 • 694 citations

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.

1993 • 683 citations

Adjuvant Therapy of Colorectal Cancer

1988 • 376 citations

Adjuvant therapy for colon and rectal cancer

1990 • 336 citations

Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer

1987 • 138 citations

The chemotherapy of colon cancer can no longer be ignored

1993 • 92 citations

Standards for the Socioeconomic Evaluation of Health Care Services

1990 • 92 citations

AXIS – A suitable case for treatment

1991 • 59 citations

A cost‐utility approach to the use of 5‐fluorouracil and levamisole as adjuvant chemotherapy for Dukes’ C colonic carcinoma

1993 • 51 citations

Treatment costs in hodgkin's disease: A cost-utility analysis

1996 • 49 citations

The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer

1996 • 42 citations

European School of Oncology advisory report to the Commission of the European Communities for the “Europe against cancer programme” cost-effectiveness in cancer care

1995 • 31 citations

Follow-up study of adjuvant chemoimmunotherapy in colorectal carcinoma after definitive surgery.

1985 • 6 citations

SHOULD PATIENTS WITH DUKES' C COLON CANCER RECEIVE ADJUVANT CHEMOTHERAPY AFTER CURATIVE RESECTION?

1991 • 4 citations